This Article  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

MARC S. KARLAN, MD; MUTAZ B. HABAL, MD; DONALD LEAKE, DMD, MD

Arch Surg. 1978;113(12):1400.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The Medical Device Amendment of May 28, 1976, to the Food and Drug Act empowers the Food and Drug Administration to regulate and set standards for all medical devices from tongue blades to dialysis units. The FDA has set up "advisory panels" with consumer, industry, and professional representation to offer it advice as to whether particular devices require standards, premarket clearance, or quality control. The involvement of nongovernmental agencies in the writing of standards is hoped for but not assured. It is unlikely that cost will be a factor in assessing safety and efficacy. There is ample opportunity during the administration of the law to "lobby" the FDA either directly, through the advisory panel hearings, or in public hearings.

Everyone interested in medical devices is concerned about their safety and efficacy. Standards themselves, however, must also be relevant, safe, efficacious, and cost-effective. Standards may be written and the law administered . . . [Full Text PDF of this Article]

Author Affiliations
Division of Otolaryngology; Division of Plastic Surgery University of Florida College of Medicine and Health Center Gainesville, FL 32610; Division of Oral Surgery Harbor General Hospital Los Angeles, CA 90509

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?